Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense
2016 ◽
Vol 10
(2)
◽
pp. 239-241
◽
2012 ◽
Vol 48
(7)
◽
pp. 1014-1022
◽
2016 ◽
Vol 111
◽
pp. S1348
2014 ◽
Vol 109
◽
pp. S142
2018 ◽
Vol 36
(15_suppl)
◽
pp. e16109-e16109
1995 ◽
Vol 30
(sup212)
◽
pp. 100-104
◽